NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.448
-0.200 (-12.14%)
Jan 21, 2026, 5:24 PM CET
NextCell Pharma AB Revenue
In the fiscal year ending August 31, 2025, NextCell Pharma AB had annual revenue of 11.06M SEK, down -1.90%. NextCell Pharma AB had revenue of 2.52M in the quarter ending August 31, 2025, with 48.67% growth.
Revenue
11.06M
Revenue Growth
-1.90%
P/S Ratio
16.59
Revenue / Employee
461.02K
Employees
24
Market Cap
183.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 11.06M | -213.75K | -1.90% |
| Aug 31, 2024 | 11.28M | -2.68M | -19.18% |
| Aug 31, 2023 | 13.96M | 7.73M | 124.03% |
| Aug 31, 2022 | 6.23M | 1.77M | 39.82% |
| Aug 31, 2021 | 4.46M | 288.92K | 6.94% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |